Article Details

Roivant Acquires 416667 Shares in Immunovant, Inc. (NASDAQ:IMVT) from Sciences Ltd.

Retrieved on: 2022-10-08 18:24:39

Tags for this article:

Click the tags to see associated articles and topics

Roivant Acquires 416667 Shares in Immunovant, Inc. (NASDAQ:IMVT) from Sciences Ltd.. View article details on hiswai:

Excerpt

These antibodies are used to combat the body's immune system. Batoclimab is a novel, fully human monoclonal antibody currently being tested in ...

Article found on: beststocks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up